product Name：D-chiro-Inositol, 1,5,6-trideoxy-3-O-beta-D-glucopyranosyl-
  • Validamycin A; Validamycin; (1S-(1a,4a,5B,6a))-1,5,6-Trideoxy-3-O-B-D-glucopyranosyl-5- (hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2- cyclohexen-1-yl)amino)-d-chiro-inositol; (1S-(1alpha,4alpha,5beta,6alpha))-1,5,6-trideoxy-4-O-beta-D- glucopyranosyl-5-(hydroxymethyl)-1-((4,5,6-trihydroxy-3- (hydroxymethyl)-2-cyclohexen-1-yl)amino)-D-chiro-inositol; 1L-(1,3,4/2,6)-2,3-Dihydroxy-6-hydromethyl-4-((1S,4R,5S,6S)- 4,5,6-trihydroxy-3-hydroxymethylcyclohex-2- enylamino)cyclohexyl beta-D-glucopyranoside; 1L-(1,3,4/2,6)-2,3-Dihydroxy-6-hydroxymethyl-4- ((1S,4R,5S,6S)-4,5,6-trihydroxy-3-hydroxymethylcyclohex-2- enylamino)cyclohexyl beta-D-glucopyranoside; D-1,5,6-Trideoxy-3-O-beta-D-glucopyranosyl-5- (hydroxymethyl)-1-((4,5,6-trihydroxy-3-(hydroxymethyl)-2- cyclohexen-1-yl)amino)-D-chiroinositol; ; (1S,2S,3R,4R,6S)-2,3-dihydroxy-6-(hydroxymethyl)-4-{[(4S,5R,6R)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl beta-D-glucopyranoside; (1R,2R,3S,4S,6R)-2,3-dihydroxy-6-(hydroxymethyl)-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl beta-D-glucopyranoside; 2,3-dihydroxy-6-(hydroxymethyl)-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl hexopyranoside
  • 37248-47-8
  • C20H35NO13
  • 497.4908
  • InChI=1/C20H35NO13/c22-3-6-1-8(12(26)15(29)11(6)25)21-9-2-7(4-23)19(17(31)13(9)27)34-20-18(32)16(30)14(28)10(5-24)33-20/h1,7-32H,2-5H2
  • D-chiro-Inositol, 1,5,6-trideoxy-3-O-beta-D-glucopyranosyl- 37248-47-8
  • 1.698g/cm3
  • 130-135℃
  • 813.658°C at 760 mmHg
  • 1.689
  • 445.885°C
  • 0mmHg at 25°C